Low-Dose Naltrexone for the Treatment of Psoriasis Vulgaris

low dose naltrexone for the treatment of psoriasis

This case study presents a 60-year-old woman came to the clinic with a history of moderate, generalized plaque psoriasis covering 10% of her body surface area (BSA). Previous treatments included narrow-band UVB phototherapy (NBUVB). At her request, the physicians prescribed low-dose naltrexone (LDN) for a six-month period. The following isRead …

Read moreLow-Dose Naltrexone for the Treatment of Psoriasis Vulgaris

Interview with Bernard Bihari, MD: Low-dose Naltrexone for Normalizing Immune System Function

  Introduction   Bernard Bihari, MD, (1931-2010) was the discoverer of the clinical effects of low-dose naltrexone (LDN) in humans. In his groundbreaking clinical trial of patients with HIV/AIDS at Downstate Medical Center in 1985-86, Dr Bihari discovered the significant effectiveness of low-dose naltrexone in protecting the battered immune systems

Read moreInterview with Bernard Bihari, MD: Low-dose Naltrexone for Normalizing Immune System Function